Boardroom Alpha Digest: Thurs, Mar 9

by | Mar 9, 2023

Executive News

  • Biogen Inc. (BIIB) chairman Stelios Papadopoulos will not stand for reelection at the annual meeting, and Caroline D. Dorsa will take over as board chair
  • Perimeter Solutions (PRM) announced he appointment of Haitham Khouri as its new CEO. He replaces Edward Goldberg who is transitioning to Vice Chair
  • Coupang (CPNG) added Ambereen Toubassy to its Board

IPOs

  • Atlas Energy Solutions Inc. (AESI) shares began trading after pricing its $324M IPO. Shares opened at $17.5, below its $18 offer price, and closed at $16.95
  • After announcing that its $9.1M IPO had priced, baby goods retailer PishPosh (BABY)‘s underwriters postponed the deal due to tepid demand. PishPosh has said it will continue to pursue an IPO at a later date.

SPACs

  • Apeiron Capital Investment Corp. (APN) entered into a business combination agreement with GIO World Health
  • Pine Technology Acquisition Corp. (PTOC) announced it would liquidate on 3/10

SPAC Calendar

Recent Analysis

Daily SPAC Update – May 24, 2024

QRDO To Liquidate at $10.96. ShoulderUp Extends with 1.1M Redemptions. BFAC Extension Vote. Churchill Investor Deck. DIST Merger Agreement.

Daily SPAC Update – May 23, 2024

MAQC + Immersed Inc. Deal Terminated. GPAC Deal Vote Set. IVCB Extends w/ 2.1M Redemptions. CVII Investor Deck. PWUP Redemption Agreement.

Subscribe to Boardroom Alpha Newsletters

Subscribe to Boardroom Alpha's research to receive the latest on governance, SPACs, and people.

Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon. 

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.  

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by BA that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.  

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.